Edition:
United Kingdom

Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

6.41USD
26 Apr 2019
Change (% chg)

$-0.05 (-0.77%)
Prev Close
$6.46
Open
$6.48
Day's High
$6.48
Day's Low
$6.36
Volume
19,775
Avg. Vol
365,398
52-wk High
$11.60
52-wk Low
$5.20

About

Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology. The Company's lead product candidate, vadadustat, is indicated for the treatment of anemia in chronic kidney disease (CKD). It is involved in... (more)

Overall

Beta: 1.38
Market Cap(Mil.): $756.61
Shares Outstanding(Mil.): 117.12
Dividend: --
Yield (%): --

Financials

  AKBA.OQ Industry Sector
P/E (TTM): -- 107.11 59.93
EPS (TTM): -2.40 -- --
ROI: -30.10 8.08 11.86
ROE: -37.86 8.26 12.88

Earnings vs. Estimates